Hint | Answer |
Blocks K channels | |
Used in refractory ventricular arrythmias and some SVT -- oral with long half life | |
Class IC drugs | |
Dofetilide | |
DOC for paroxsymal supraventricular tachycardia and V tach | |
DOC for ventricular arrhythmias, esp. post-MI and cardioversion | |
SE: torsades de pointes | |
MOA: high affinity for blockade of open Na channels and also K channels -->decrease phase 0 depolarizing slope, prolong AP, decrease phase 4 spontaneous depolarization | |
SE: least toxic for cardiac arrhythmias, CNS, drowsiness, slurred speech, paresthesia, agitation, convulsions | |
Class IC drug with weak beta blocking activity | |
Used in conversion in a fib and a flutter | |
Quidine is metabolized by the ..... | |
MOA: beta-1 selective beta blockade | |
Decreases sudden death MI for sustained ventricular tachycardia | |
IV only class 1B drug with a wide therapeutic window | |
Amiodarone | |
Class IB drugs | |
Class IV drugs | |
Caution in CHF, asthmas, COPD, MAOI, eldery, depressed, PVD | |
Sotolol | |
Used in rate control for supraventricular arrythmias including A fib, A flutter | |
Other: Used in digitalis associated arrhythmias, torsades de pointes, and acute MI | |
MOA: decrease phase 4 spontaneous depolarization, slows conduction in cells dependent on Ca current. Also vasodilates | |
Ibutilide | |
Procainamide is excrexted by the.... | |
Class IB drug with pulmonary fibrosis as a side effect | |
Contraindicated in WPW | |
| Hint | Answer |
MOA: non-selective beta blockade | |
Disopyramide is excreted by the.... | |
SE: safe, flushing, SOB, hypotension, transient asystole | |
Class II Drugs | |
SE: arrythmias, N/V, diarrhea, cinchonism, displaces digoxin from tissue binding site, thrombocytopenia, hepatitis, angioneurotic edema | |
MOA: blockade of open and inactivated sodium channels -> no effect on AP duration, slows phase 0 depolarization, decreases conduction velocity | |
Class II drug used in surgery and acute arrhythmias | |
Need to monitor PFTs, LFTs, and TFTs | |
Na channel blocker | |
Used in supraventricular and ventricular tachy-arrhythmias, paroxsymal A fib | |
Class III drugs with high affinity for inactive channels | |
Class IA Drugs | |
Preferential for ectopic arryhythmias and ventricular arrhythmias d/t increased automaticity and reentry | |
SE: more pronounced SA and AV block, lupus erythmatosus like syndrome, ganglion blockade | |
Class IA drug that also blocks alpha-R | |
Other antiarrhythmias | |
MOA: partial beta agonist | |
SE: profound anti-muscarinic effects, dry mouth, urinary retention, blurred vision, constipation, confusion, convulsions, etc. | |
Used to maintain SR after cardioversion of A fib and A flutter | |
Other: Used in SV arrhythmias, Afib, Aflutter, controls ventricular response rate | |
Class IA drug that also blocks N-R | |
MOA: blockade of open and inactivated sodium channels -> shortened AP, decreased slope of repolarization, and shortened phase 3 repolarization | |
Bretylium | |
Used in life threatening ventricular arrhythmias when lidocaine and cardioconversion have failed | |
Class III IV only | |
SE pulmonary fibrosis, liver tox, hypothyroid, photosensitivty, corneal discoloration, blue skin | |
|
Show Comments